ESC/EASD Joint Guidelines on Diabetes and Cardiovascular Diseases

被引:0
|
作者
Motz, Wolfgang [1 ]
Doerr, Rolf [2 ]
机构
[1] Klin Grp Dr Guth GmbH & Co KG, Klinikum Karlsburg, D-17495 Karlsburg, Germany
[2] Akad Lehrpraxisklin TU, Praxisklin Herz & Gefasse Kardiol Angiol Radiol N, Dresden, Germany
关键词
Diabetes mellitus; Prediabetes; Cardiovascular diseases; Coronary heart disease; Coronary artery disease equivalent; Risk factors; Coronary revascularization; CORONARY-HEART-DISEASE; DRUG-ELUTING STENTS; ELEVATION MYOCARDIAL-INFARCTION; SUDDEN CARDIAC DEATH; BLOOD-PRESSURE; CLINICAL-OUTCOMES; GLUCOSE-TOLERANCE; RISK-FACTORS; FOLLOW-UP; MELLITUS;
D O I
10.1007/s00059-009-3203-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ESC/EASD (European Society of Cardiology/European Association for the Study of Diabetes) joint Guidelines on diabetes, pre-diabetes, and cardiovascular diseases have, for the first time, addressed diabetes mellitus and cardiovascular diseases (CVD) as a pathophysiological entity in Europe. Based on these guidelines, diabetes mellitus is regarded from the outset to be a cardiovascular disease, whose life-threatening complications myocardial infarction and stroke can only be avoided by an interdisciplinary concerted action. The most important information of these guidelines for the interdisciplinary cooperation of primary-care physicians, diabetologists and cardiologists are the postulations that patients with the main diagnosis diabetes mellitus with or without known CVD should, at regular intervals, be referred to a cardiologist, and patients with the main diagnosis CVD with or without diabetes mellitus should, at regular intervals, be referred to a diabetologist. Of fundamental importance is the prevention of diabetes and CVD by a comprehensive lifestyle modification including smoking cessation, regular physical activity and weight control, flanked by an evidence-based drug therapy. Within the framework of a multimodal risk management, an optimal antihypertensive therapy of a concomitant elevated blood pressure; a statin therapy in case of elevated LDL cholesterol or regardless of an elevated LDL in proven CVD; ACE inhibitors, angiotensin II receptor blockers, or beta-blockers in case of heart failure; and an anticoagulant therapy for the prevention of cardioembolic stroke in patients with atrial fibrillation all have class I recommendations. Concerning the preferred coronary revascularization procedure in diabetics, today no rigid general recommendation can be given in favor of or against coronary bypass surgery, or in favor of or against percutaneous coronary intervention. The decision for a specific revascularization procedure should, in any case, be based on a detailed analysis of the individual coronary anatomy.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 50 条
  • [1] ESC/EASD joint guidelines on diabetes and cardiovascular diseases [ESC/EASD-leitlinien zu diabetes und kardiovaskulären erkrankungen]
    Motz W.
    Dörr R.
    Herz Kardiovaskuläre Erkrankungen, 2009, 34 (1) : 21 - 29
  • [2] ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
    Ryden, Lars
    Grant, Peter J.
    Anker, Stefan D.
    Berne, Christian
    Cosentino, Francesco
    Danchin, Nicolas
    Deaton, Christi
    Escaned, Javier
    Hammes, Hans-Peter
    Huikuri, Heikki
    Marre, Michel
    Marx, Nikolaus
    Mellbin, Linda
    Ostergren, Jan
    Patrono, Carlo
    Seferovic, Petar
    Uva, Miguel Sousa
    Taskinen, Marja-Riita
    Tendera, Michal
    Tuomilehto, Jaakko
    Valensi, Paul
    Zamorano, Jose Luis
    EUROPEAN HEART JOURNAL, 2013, 34 (39) : 3035 - +
  • [3] ESC Guidelines on diabetes, pre- diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary
    Ryden, Lars
    Grant, Peter J.
    Anker, Stefan D.
    Berne, Christian
    Cosentino, Francesco
    Danchin, Nicolas
    Deaton, Christi
    Escaned, Javier
    Hammes, Hans-Peter
    Huikuri, Heikki
    Marre, Michel
    Marx, Nikolaus
    Mellbin, Linda
    Ostergren, Jan
    Patrono, Carlo
    Seferovic, Petar
    Sousa, Miguel
    Taskinen, Marja-Riita
    Tendera, Michal
    Tuomilehto, Jaakko
    Valensi, Paul
    Luis Zamorano, Jose
    Luis Zamorano, Jose
    Achenbach, Stephan
    Baumgartner, Helmut
    Bax, Jeroen J.
    Bueno, Hector
    Dean, Veronica
    Deaton, Christi
    Erol, Cetin
    Fagard, Robert
    Ferrari, Roberto
    Hasdai, David
    Hoes, Arno W.
    Kirchhof, Paulus
    Knuuti, Juhani
    Kolh, Philippe
    Lancellotti, Patrizio
    Linhart, Ales
    Nihoyannopoulos, Petros
    Piepoli, Massimo F.
    Ponikowski, Piotr
    Sirnes, Per Anton
    Luis Tamargo, Juan
    Tendera, Michal
    Torbicki, Adam
    Wijns, William
    Windecker, Stephan
    De Backer, Guy
    Sirnes, Per Anton
    DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (03) : 133 - 173
  • [4] 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
    Cosentino, Francesco
    Grant, Peter J.
    Aboyans, Victor
    Bailey, Clifford J.
    Ceriello, Antonio
    Delgado, Victoria
    Federici, Massimo
    Filippatos, Gerasimos
    Grobbee, Diederick E.
    Hansen, Tina Birgitte
    Huikuri, Heikki, V
    Johansson, Isabelle
    Juni, Peter
    Lettino, Maddalena
    Marx, Nikolaus
    Mellbin, Linda G.
    Ostgren, Carl J.
    Rocca, Bianca
    Roffi, Marco
    Sattar, Naveed
    Seferovic, Petar M.
    Sousa-Uva, Miguel
    Valensi, Paul
    Wheeler, David C.
    Piepoli, Massimo Francesco
    Birkeland, Kare, I
    Adamopoulos, Stamatis
    Ajjan, Ramzi
    Avogaro, Angelo
    Baigent, Colin
    Brodmann, Marianne
    Bueno, Hector
    Ceconi, Claudio
    Chioncel, Ovidiu
    Coats, Andrew
    Collet, Jean-Philippe
    Collins, Peter
    Cosyns, Bernard
    Di Mario, Carlo
    Fisher, Miles
    Fitzsimons, Donna
    Halvorsen, Sigrun
    Hansen, Dominique
    Hoes, Arno
    Holt, Richard I. G.
    Home, Philip
    Katus, Hugo A.
    Khunti, Kamlesh
    Komajda, Michel
    Lambrinou, Ekaterini
    EUROPEAN HEART JOURNAL, 2020, 41 (02) : 255 - 323
  • [5] ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
    Ryden, Lars
    Grant, Peter J.
    Anker, Stefan D.
    Berne, Christian
    Cosentino, Francesco
    Danchin, Nicolas
    Deaton, Christi
    Escaned, Javier
    Hammes, Hans-Peter
    Huikuri, Heikki
    Marre, Michel
    Marx, Nikolaus
    Mellbin, Linda
    Ostergren, Jan
    Patrono, Carlo
    Seferovic, Petar
    Uva, Miguel Sousa
    Taskinen, Marja-Riita
    Tendera, Michal
    Tuomilehto, Jaakko
    Valensi, Paul
    Zamorano, Jose Luis
    KARDIOLOGIA POLSKA, 2013, 71 : S319 - S394
  • [6] Comments on the 2013 ESC/EASD guidelines on diabetes, prediabetes and cardiovascular diseases
    Motz, W.
    Kerner, W.
    Doerr, R.
    HERZ, 2014, 39 (08) : 971 - 982
  • [7] Comments on the 2013 ESC/EASD guidelines on diabetes, prediabetes and cardiovascular diseases
    Motz, W.
    Kerner, W.
    Doerr, R.
    HERZ, 2014, 39 (08) : 971 - 982
  • [8] 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Summary of the document prepared by the Czech Society of Cardiology
    Taborsky, Milos
    Linhart, Ales
    Rosolova, Hana
    Spinar, Jindrich
    COR ET VASA, 2020, 62 (02) : 105 - 138
  • [9] Diabetes, pre-diabetes and cardiovascular diseases in light of the 2019 ESC Guidelines
    Zandecki, Lukasz
    Janion-Sadowska, Agnieszka
    Kurzawski, Jacek
    Janion, Marianna
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2020, 36 (02) : 148 - 155
  • [10] Joint ESC/EASD Guidelines on Diabetes, where are we Now and where should we Go?
    Ryden, Lars
    Mellbin, Linda
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (06) : 690 - 692